GLP-1 Medicines and Blood Pressure: Can Semaglutide or Tirzepatide Lower BP?

By Dr. Moxit Shah, DM Endocrinology | Vishuddha Endocrine Clinic, Ahmedabad

“Doctor, I started a weight-loss medicine, and now my blood pressure readings are lower. Can I stop my BP tablets?” This is an important question because weight-loss treatment can affect more than the number on the scale.

Quick answer: GLP-1 medicines such as semaglutide and dual GIP/GLP-1 treatments such as tirzepatide can modestly reduce blood pressure in appropriately selected patients, often alongside weight loss. They are not a replacement for prescribed hypertension medicines, and low BP or dehydration needs medical attention.

Why blood pressure matters during medical weight loss

High blood pressure, increased abdominal fat, insulin resistance, type 2 diabetes, sleep apnoea and fatty liver often occur together. Sustained high blood pressure raises the risk of heart attack, stroke, kidney disease and heart failure. For patients using GLP-1–based treatment for an approved indication, tracking blood pressure alongside weight and glucose helps measure broader metabolic health.

Do GLP-1 medicines lower blood pressure?

They often lead to modest reductions in blood pressure, particularly when they produce meaningful weight loss. Semaglutide is a GLP-1 receptor agonist, while tirzepatide acts on both GIP and GLP-1 receptors. In trials of adults with overweight or excess weight, these medicines have reduced average systolic blood pressure. Their main purpose depends on the approved product indication; they should not be prescribed solely as replacements for established blood pressure medicines.

People respond differently. If blood pressure improves while taking these medicines, it does not mean antihypertensive tablets can be stopped independently.

How much blood pressure reduction is possible?

A 2025 systematic review and meta-analysis of randomized trials found that GLP-1 receptor agonists reduced average systolic blood pressure by approximately 3.4 mmHg compared with control groups, with larger average reductions seen for dual incretin agonists in the populations studied. These are pooled research findings, not guaranteed individual results.

In a post-hoc analysis of the SURMOUNT-1 tirzepatide trial, average placebo-adjusted changes at 72 weeks were approximately 6.8 mmHg systolic and 4.2 mmHg diastolic across the tirzepatide groups, with much of the reduction statistically associated with weight loss. The trial enrolled adults with overweight or excess weight and did not establish tirzepatide as a replacement for treatment of hypertension.

Why might blood pressure improve?

When body weight and visceral fat decrease, some people experience improved vascular and metabolic function. Changes in dietary intake, physical activity, sleep and other behaviours may also contribute. Researchers are investigating possible direct effects of incretin therapies on the cardiovascular and renal systems; the precise contribution of weight-independent mechanisms remains uncertain.

Remember that the heart benefits of specific GLP-1 medicines depend on the studied population and product indication. Improving a blood pressure reading does not automatically prove prevention of a heart attack or stroke for every person taking one of these treatments.

Could blood pressure become too low during GLP-1 treatment?

Yes, particularly when weight decreases, food or fluid intake is poor, or a person already takes medicines that lower blood pressure. Dehydration from vomiting or diarrhoea can make dizziness, weakness and low blood pressure more likely. Symptoms may include light-headedness on standing, fainting, weakness or unusually low readings.

Do not skip blood pressure tablets, diuretics or GLP-1 doses without contacting your clinician. If you develop persistent dizziness, fainting, severe dehydration or a sudden deterioration in health, seek timely medical assessment. Learn more about GLP-1 medicines, dehydration and kidney health.

How to measure blood pressure correctly at home

1. Use a validated automatic upper-arm monitor with the correct cuff size.
2. Avoid caffeine, smoking and exercise for around 30 minutes before checking.
3. Rest quietly for at least five minutes, with your back supported and feet flat on the floor.
4. Support your arm at heart level; place the cuff directly on bare skin.
5. Take two readings about one minute apart, record both and review trends with your clinician.

The American Heart Association advises home blood-pressure monitoring for people with hypertension. One isolated reading is not sufficient to judge overall control. For concerning readings or symptoms, follow your individual emergency plan.

What else should you monitor during GLP-1 weight loss?

• Weight and waist: look at gradual trends rather than daily changes.
• Glucose and HbA1c: especially if you have diabetes or take insulin or a sulfonylurea.
• Hydration and side effects: monitor nausea, vomiting, bowel symptoms and fluid intake.
• Nutrition and strength: maintain adequate protein and appropriate resistance exercise.
• Blood pressure and medicines: review any changing readings with your treating clinician.

You may also find our articles on waist reduction with GLP-1 medicines, health benefits of 5–15% weight loss, and preserving muscle during weight loss helpful.

Can someone with hypertension take semaglutide or tirzepatide?

High blood pressure alone is not necessarily a reason to avoid GLP-1-based treatment. However, treatment should be considered for an appropriate approved indication and after reviewing other diseases, current prescriptions, pregnancy plans and product-specific contraindications and precautions. Certain medicines carry contraindications relating to medullary thyroid carcinoma or MEN2. The right treatment is based on overall cardiovascular, metabolic and weight-related risk—not one number.

Frequently asked questions

Can semaglutide lower blood pressure?

It may modestly lower average blood pressure in patients receiving treatment for a suitable indication, particularly with weight reduction. It is not a direct substitute for blood pressure medicine.

Does tirzepatide help hypertension?

Studies have found reductions in average blood pressure during tirzepatide-associated weight loss, but patients with hypertension still need individualized blood pressure care.

Should I stop my BP tablets if I lose 10 kg?

No. Ask your clinician to review your logged readings and other risk factors before considering medication adjustments.

Can GLP-1 medicine make me dizzy?

Dizziness can occur for several reasons, including dehydration or low blood pressure. Check blood pressure and seek medical advice, particularly if symptoms persist.

Is low blood pressure dangerous?

Symptoms matter. Repeated low readings with fainting, weakness or dehydration warrant medical assessment. Seek emergency care for collapse or severe symptoms.

How often should I check BP?

The schedule varies, but regular home measurements are useful after medication or weight changes. Your doctor can recommend how often to record readings.

GLP-1 and weight-loss care in Ahmedabad

If you have elevated blood pressure, type 2 diabetes or weight-related health concerns, an endocrinology consultation can help coordinate treatment and ongoing monitoring.

Dr. Moxit Shah, DM Endocrinology
Vishuddha Endocrine Clinic
104–105, Elite Magnum, Bhuyangdev Cross Road, Ghatlodiya, Ahmedabad – 380061, Gujarat, India.
Appointments: +91 99799 92797
Find the clinic on Google Maps.

References and medical disclaimer

1. Effect of incretin-based therapies on blood pressure: a systematic review and meta-analysis (2025). PubMed.
2. Tirzepatide and blood pressure reduction: stratified analyses of the SURMOUNT-1 randomized controlled trial. Heart, 2024.
3. Tirzepatide Reduces 24-Hour Ambulatory Blood Pressure in Adults With BMI ≥27 kg/m²: SURMOUNT-1 ABPM substudy. Hypertension, 2024.
4. American Heart Association. Home Blood Pressure Monitoring.

This article is intended for general patient education. Medicines, doses and blood-pressure targets must be individualized. Always follow approved Indian product labels and your treating physician’s advice.